{"name":"Portal Therapeutics, Inc.","slug":"portal-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPak1jd0hGdENEeDB1bXAwZzdIc3VzUjdpUnY2SFJvMTdPRDcwdTZkNm9hcTl3MmE2Uk1GMTFIUVZlTngzYlVNeTd4SEt6bFRDTTFLYm5zZWk3SUxFSmVWMUszcURJMlYtOXppR0t6TzB2bnJIbFJYa3RWTEZQdGJhcjhPX1hxWFkxZllyc3FOY2FDYm9tbUc2dkxvOHFENkxldDFUZk40a2VLdS1WQVFPM2VDamNVV0xrNHNtWXJhUHVyZVpmaGxTT0xxR3lQQWM?oc=5","date":"2026-03-18","type":"pipeline","source":"prnewswire.com","summary":"BoomRx Expands Access to Peptide Therapies Through Centralized Pharmacy Portal - prnewswire.com","headline":"BoomRx Expands Access to Peptide Therapies Through Centralized Pharmacy Portal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQSjJsT0I3blBvV2pvMmxEZzdvMlBzVmNzM3lhbU1TS3FacW5CSzFKTmVmTnpXcnBrS0VxOXlvMlZMNTdkZExuc1VNVnFLTGgtOTZwX29fVXd1aTBrTWZZYTJobTRpbFRYXzR1NjdFcUh5SDNuTWxGb0ZPZV9FX2p2bnVXcVQ5cEIzcHBHVkpPanVvZERoMktwUl9GNW0tNWtRRWFfOC1qd1lOTkgxZzA5Wmg2SQ?oc=5","date":"2026-02-26","type":"trial","source":"Stock Titan","summary":"Belapectin Phase 3 data: potential first treatment for MASH varices - Stock Titan","headline":"Belapectin Phase 3 data: potential first treatment for MASH varices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZGhwWjNqdTR5SG96VHlWM0pQalhqM0ItaHdneFNGczFHM3RWUmN6X3pDanZMM05IVXI3Ri1ldjlaRHZ3VE5nc2hGSHRTNlpoVENyOHl0ZFc2SldzdC1fN3NGZWpWOWl5TWlGakx5dHlCY2c3UmJBNzB2VW45UXAxaHZQTUQ3Mmdo?oc=5","date":"2026-02-23","type":"pipeline","source":"Yahoo Finance","summary":"PorTal Access, Inc. Appoints Industry Veteran David Snow to Board of Directors to Advance Next-Generation Oncology Vascular Access Solutions - Yahoo Finance","headline":"PorTal Access, Inc. Appoints Industry Veteran David Snow to Board of Directors to Advance Next-Generation Oncology Vascu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQdVRRVS1YbnZoNFNEOWx0WTFQTVEyT0xBTWFYTk9ZRFFQVl84SXFpUmpYN3ItbFY5R3Z3NVB2WVFabW9MeXlsLWJHMWo4VEZORjZnV0piWmpTLWdRUFJhcHJCNG1hWER6U0xGZU5KVDdkS2dKd2hFT3l3NFB2RTBpNGhhYlgxQXVtUmxIRFFkR1JxMlVtVmEyZF85QWs2T20tQXhxeDlscjRNZjZUVmVTbTg3RDlIRUhOZDNtRnRYZmVQYlJ2Mm43eS03WEZjUzB6OVE?oc=5","date":"2025-10-13","type":"pipeline","source":"Reuters","summary":"Pharma companies announce direct-to-consumer sales and price cuts in US - Reuters","headline":"Pharma companies announce direct-to-consumer sales and price cuts in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQSkdGaTU3OF9YSUE4OUNOOHFaZ0JoeG5mRk15a2kwdVV4Y3IyTl8xaEx2bkpEYzlUdDlQR2FGNHB6R0FqWHg0ZE5UY1h2dzJBUkhjcjJSMU5DZWtmZ2c1cEQxY1lPRlVYZ3dkQ2sxTVBDY1lXaWtYS28tN28zdEdDZ3NsSzEzb2R4ZU5udTVwV09lYVFUcGc?oc=5","date":"2025-10-01","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"New Jersey is Poised to Become a Life Sciences Leader - Genetic Engineering and Biotechnology News","headline":"New Jersey is Poised to Become a Life Sciences Leader","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOOXNzVU9FdmVLdXFSY3VXYjFuVy1GZ2FvRDhYNl9pdkNxalR6MjJNQVhxM3pFYy1SamQ0VkdSX2Jmc3B5NGY2MHVZbjFtaFE5MDEyeVJWWE5vNDVqdU1UazBTNlVtb1p4eUdvUGtrMDZFRF90STh1cnNoeG84QzN1UElmV3BVYzQtaWxVUm03aDQzWWdqUjZSRXhUeHVDcDVyTmVBX05KWVJkQQ?oc=5","date":"2025-09-24","type":"pipeline","source":"Rhode Island Current","summary":"Fab Five: First Ocean State Labs life sciences tenants announced - Rhode Island Current","headline":"Fab Five: First Ocean State Labs life sciences tenants announced","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPWS1zM3dsbDVrQVo0c3J5T0ZVNGdwSS1fSzByOFpkbzdReXcydE1rWkxCRHVqcktDUUhadWNDWnRzaGpJQS1BNEFjbkwwQ2hKd0lyMGRMXzZJbVVhZVhFSldNWk1OLWFYb1pyRkJmRS1nM25hSG1lMC1ILWdmMU0wcnRRVHdpbjhOSzBCWnFITVRaeWpfcXJMdVZ6UEN2QmNhVm9IMC1wSHNMZEhielhSajFJVDN3OWM?oc=5","date":"2025-07-15","type":"pipeline","source":"Bloomberg.com","summary":"How Novo Nordisk Rival Hims Became King of Knockoff Weight-Loss Drugs - Bloomberg.com","headline":"How Novo Nordisk Rival Hims Became King of Knockoff Weight-Loss Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNQWlUYkNJQUFZbXpTc29VZzBHNkxaWUxtSHNHeGdfRXBvdXlRM1hPQUlHc2pFVy1zR0JXYTR5dFlYQnFRRmxpbWs3ZkY5Ul9mTGhONThRc05sbkdSNDhwYkc2dDZWbzJSRXVRYktkNXlmaVJ3ZklmR1JZNVlQT3RQQllBT1YyajFLMDVlamlCS3JMZmxaaTB4WkdELVlQNF8wNzJQT05hSHoyOVJvTXZuSTEteVgwaDdPSFpDZzFiS1l3WEtyR192Y3VPUzUzRzRvZVl3VG5YMzRnclhGbkRzYnpZNG9zU1FjTDVhS1RNeEdKb3BtRmloY1Vhd2Jmak9xN0FWRVdUVXZmZXZGZnJhN1lteW9za2toQVdXMy04U25oSmkzQ25RcnBhYjF0RWthWWIyd3JqSFZYUVZaVHRfT0pYSQ?oc=5","date":"2025-06-24","type":"pipeline","source":"BioSpace","summary":"Portal Biotechnologies Awarded $8M DARPA Contract to Increase Access to Cell Therapy via a Portable, Red Blood Cell Engineering Device for Rapid Point-of-Care Production and Treatment - BioSpace","headline":"Portal Biotechnologies Awarded $8M DARPA Contract to Increase Access to Cell Therapy via a Portable, Red Blood Cell Engi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPMHRkMkFkNXQ0SU9GMHF2RF8tSVFkcnhsSVM1dk1OQUZYNnhualFtaElESlJCRXRsd3NzZUdlanpLVnpYblJTY2hielBFVnczdkFNWktWeUNiZ0pVQTdheWE2ZnNVX3dKXzhFeUtTZmJnQ3lSUjNvUTgzOHNIZFJ0TlBaUElqU2JyYlJSNU5uWUFqMW8?oc=5","date":"2025-05-01","type":"pipeline","source":"BioPharma Dive","summary":"Siren, a gene therapy startup, tests unconventional alternative to venture funding - BioPharma Dive","headline":"Siren, a gene therapy startup, tests unconventional alternative to venture funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE16Tjd4eDJhckluS2hZMDRqRVhNcDVkd3QxM25NdXZFRmRCYnFzWWotbmczQndmNEFmRGt2X014dG9rSkV2YzNRcnlHV3dKcDIwUFdjckdYYlRiY25vNWZ3?oc=5","date":"2024-12-04","type":"pipeline","source":"Nature","summary":"Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria - Nature","headline":"Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPQWFZb282R2FYODVqalpCYXJFNmhxbldQcFE5RXM1MVE0Z0Mtc2cwdXJ1dEItNFRPVk9xalY0WHdjRFlFTk5vaXJEemFoZFFXWWM4UlNsam9KQTJWQmdUcjBCeGhYWTdHdkhoam5SMS1HNWhWV2RYeFJOWDRqLWVzRFNDYVhsUHRpQlkwNVJ1OTA?oc=5","date":"2024-05-29","type":"pipeline","source":"Pharma Voice","summary":"Can robots break the cell therapy bottleneck? - Pharma Voice","headline":"Can robots break the cell therapy bottleneck?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQMWNGWXFsek81aXpzdG5LX2ZTWWxBY2IzaE5Kdmllb0hwdUplemZfdVJ2Mjk5U01fX3FMTk5zU1JlTEYwVU9mUE9ROTJpTTdNOVdzQjQ5WXlhYTFvcHdwekdNZXI3WmNZYXpheHhnUHd1Y3F5djV4b2RiVEtLUGt2RUJMSUY1V2pGQzhMNVk4U0UxM1ZjVkE?oc=5","date":"2023-12-12","type":"pipeline","source":"businesswire.com","summary":"Introducing Portal Biotechnologies - businesswire.com","headline":"Introducing Portal Biotechnologies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}